Le Lézard
Classified in: Health
Subject: FVT

Go-To-Market Success: The Role of Capital Preservation in Life Science Research and Diagnostic Consumable Manufacturing, Upcoming Webinar Hosted by Xtalks


In this free webinar, discover strategies for saving capital and reducing time to market in the development and manufacturing of diagnostic and life science consumables. The featured speakers will discuss the purpose-built infrastructure and pilot line capabilities at SCHOTT MINIFAB. Attendees will learn about the benefits of outsourcing, including reduced capital investment and faster time to market. The speakers will also discuss the factors to consider when weighing up the costs of outsourcing vs. insourcing.

TORONTO, April 9, 2024 /PRNewswire-PRWeb/ -- In this webinar, Patrick Tuohy and James Downs will address a critical question encountered by most life science and diagnostic companies: Should the development and/or manufacturing of products be outsourced or in-sourced? The webinar delves into how a leading solutions provider for microfluidic devices and microarray assays can assist companies in saving capital and reducing time to market by outsourcing their development and manufacturing needs.

By focusing on core competencies, minimizing capital investments and embracing production flexibility, businesses can more efficiently navigate the journey from development to product launch by entering into collaborations.

Business leaders in diagnostic and life science companies grapple with the challenging decision of how to produce their products. By focusing on core competencies, minimizing capital investments and embracing production flexibility, businesses can more efficiently navigate the journey from development to product launch by entering into collaborations.

In this webinar, the expert speakers will explore how life science and diagnostic companies can leverage pilot line capability. This capability consists of purpose-built manufacturing expertise within SCHOTT MINIFAB, enabling the transformation of clients' products from initially assembled units (for feasibility testing) to the first commercial articles that contribute to improving patient health and well-being.

A common objection faced by companies is that insourcing is cheaper than outsourcing. It is crucial to understand the true costs, including those associated with capability development, facilities, equipment, administrative overhead and per capita expenses. In this webinar, the experts will thoroughly consider all relevant factors related to the development and manufacturing of products.

Register for this webinar to discover strategies for saving capital and reducing time to market in the development and manufacturer of diagnostic and life science research consumables.

Join experts from SCHOTT MINIFAB, Dr. James Downs, Business Development Manager, US; and Patrick Tuohy, Business Development Manager, EMEA, for the live webinar on Thursday, April 25, 2024, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Go-To-Market Success: The Role of Capital Preservation in Life Science Research and Diagnostic Consumable Manufacturing.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com 

SOURCE Xtalks


These press releases may also interest you

at 17:05
Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2, showing that the investigational compound elinzanetant significantly reduced frequency and severity of moderate to severe vasomotor symptoms (VMS; also known as hot...

at 16:56
In honor of Mental Health Awareness Month, the Behavioral Health Leaders Network, a Kinetix Group network of excellence, announced it will rebrand as the Brain Health Leaders Network (BHLN)....

at 16:55
There is a new beauty breakthrough with Dr. Simon Ourian's new cellulite removal treatment that redefines smooth skin. At Epione we are proud to unveil...

at 16:50
For the second consecutive year, Ampersand Capital Partners is ranked #1 globally by HEC Paris-DowJones for growth capital private equity performance. HEC Paris analyzed performance data from 106 Growth Capital firms and the 279 funds they raised...

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 2,910,780 shares of Geron common stock as inducements to newly hired employees in...

at 16:15
Quest Diagnostics , a leading provider of diagnostic information services, today announced that its Board of Directors has elected Robert (Rob) B. Carter, a seasoned technology executive, to serve as a director. Including Mr. Carter, the company's...



News published on and distributed by: